Literature DB >> 15958896

Cementless hip arthroplasty in juvenile idiopathic arthritis.

Thierry Odent1, Pierre Journeau, Anne-Marie Prieur, Philippe Touzet, Jean-Claude Pouliquen, Christophe Glorion.   

Abstract

Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. The hip is usually affected later, and its involvement is the most common cause of disability in JIA. Failure of medical and preventive treatment, significant joint destruction, or multiarticular involvement may necessitate total hip arthroplasty (THA) to restore good function. Related clinical trials show initially good THA results in most of the series, but long-term outcomes are uncertain due to a significant arthroplasty loosening rate in the initial years, particularly with cemented stems. The authors report the results of 62 noncemented THAs in 34 children with JIA after an average follow-up of 6 years (range 3-13). Mean age at surgery was 18.3 years (range 11.8-31) and 14 of the 34 children had active disease. Clinical results were good for hip function but less for global function. There were no infections. Two acetabular cups early in the series failed due to poor primary fixation and had to be revised. Survivorship analysis was performed with the Kaplan-Meier method. At 13 years, the survival rate was 100% for the femoral component and 90.1% for the acetabular component.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958896     DOI: 10.1097/01.bpo.0000161096.53963.0e

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  15 in total

1.  Alumina-on-alumina THA in patients with juvenile idiopathic arthritis: a 5-year followup study.

Authors:  Ana Cruz-Pardos; Eduardo García-Rey; Eduardo García-Cimbrelo; Jose Ortega-Chamarro
Journal:  Clin Orthop Relat Res       Date:  2011-08-31       Impact factor: 4.176

Review 2.  [Juvenile rheumatoid diseases: Endoprosthetic care of destroyed hip joints].

Authors:  S Rehart; M Henniger
Journal:  Orthopade       Date:  2015-07       Impact factor: 1.087

3.  Long Term Outcomes of Total Hip Arthroplasty in Young Patients under 30.

Authors:  Emilios E Pakos; Nikolaos K Paschos; Theodoros A Xenakis
Journal:  Arch Bone Jt Surg       Date:  2014-09-15

4.  Risk factors for revision of hip arthroplasties in patients younger than 30 years.

Authors:  Julien Girard; Christophe Glorion; François Bonnomet; Damien Fron; Henri Migaud
Journal:  Clin Orthop Relat Res       Date:  2010-11-18       Impact factor: 4.176

5.  Hyaluronic Acid Therapy in Hip OA Does Not Perform Equally in Osteoarthritis Secondary to Juvenile Idiopathic Arthritis When Compared to Primary Osteoarthritis: A 2-Year Preliminary Evaluation.

Authors:  Rolando Cimaz; Roberto Caporali; Orazio De Lucia; Angela Flavia Luppino; Francesca Pregnolato; Antonella Murgo; Irene Pontikaki; Maurizio Gattinara; Tania Ubiali
Journal:  Adv Ther       Date:  2022-01-16       Impact factor: 3.845

6.  Cemented polyethylene cups in patients younger than 40 years.

Authors:  Daniël C J de Kam; Jean W M Gardeniers; Jan C M Hendriks; René P H Veth; B Willem Schreurs
Journal:  Clin Orthop Relat Res       Date:  2009-04-16       Impact factor: 4.176

Review 7.  Total joint replacement in childhood arthritis.

Authors:  Han Jo Kim; Barbara Kahn; Mark P Figgie
Journal:  Curr Rheumatol Rep       Date:  2008-04       Impact factor: 4.592

8.  High complication rate in revision total hip arthroplasty in juvenile idiopathic arthritis.

Authors:  Stuart B Goodman; Katherine Hwang; Susanna Imrie
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

9.  Hip resurfacing in patients under thirty years old: an attractive option for young and active patients.

Authors:  Nicolas Krantz; Bruno Miletic; Henri Migaud; Julien Girard
Journal:  Int Orthop       Date:  2012-05-11       Impact factor: 3.075

10.  Long-term results of cemented total hip arthroplasty in patients younger than 30 years and the outcome of subsequent revisions.

Authors:  Marloes W J L Schmitz; Vincent J J F Busch; Jean W M Gardeniers; Jan C M Hendriks; René P H Veth; B Willem Schreurs
Journal:  BMC Musculoskelet Disord       Date:  2013-01-22       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.